The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity.
about
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathyIntravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathyDecompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathyDecompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathyDrug therapy for chronic idiopathic axonal polyneuropathyTreatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patientsEntrapment neuropathies in diabetes mellitusThe effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort studyDiabetic neuropathy: mechanisms to managementFour-year sequential nerve conduction changes since first visit in Japanese patients with early type 2 diabetesDiabetic neuropathy part 1: overview and symmetric phenotypesCorneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy.Measurement of cooling detection thresholds for identification of diabetic sensorimotor polyneuropathy in type 1 diabetesIdentification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters.Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.Gastrointestinal disturbances in diabetes.Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy.Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy studyReliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibilityDistal symmetrical polyneuropathy: definition for clinical research.Effects of antiretroviral therapy on autonomic function in early HIV infection: a preliminary report.Diabetes mellitus and the nervous systemA Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis.Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosisEvaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review).Glucose control and diabetic neuropathy: lessons from recent large clinical trials.Neurologic complications of diabetes.Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.A 70-year-old male with peripheral neuropathy, ataxia and antigliadin antibodies shows improvement in neuropathy, but not ataxia, after intravenous immunoglobulin and gluten-free dietDiagnostic approach to peripheral neuropathyThere is No Association between Cardiovascular Autonomic Dysfunction and Peripheral Neuropathy in Chronic Hemodialysis Patients.A novel quantitative method for diabetic cardiac autonomic neuropathy assessment in type 1 diabetic mice.Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy.Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.Oxaliplatin-induced neurotoxicity and the development of neuropathy.Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities.Future needs in peripheral neuropathy outcome measures.Do we underestimate influences of diabetic mononeuropathy or polyneuropathy on hand functional performance and life quality?
P2860
Q24201573-9B401D10-937C-4A08-8188-D96A4B388721Q24240936-682422A5-5F3E-4CDF-936B-3ABD8A74CFF6Q24242212-7EA50E97-FA79-4D09-858E-C19A6C7012DDQ24245789-0FB9E27A-085D-4B21-B367-A819CABD97C5Q24247228-097B647E-B080-4FE2-917F-0DFEDB270E2CQ24646981-FF026C37-9B38-4640-B857-376493E506B5Q28067642-CB12F377-B98F-4B7B-9C56-7D05789864CFQ28393832-BB500338-CAD0-4FC1-8E36-787099021235Q33554384-626C53D7-E7A8-4ED3-A21C-1BD089BAFA0BQ33633642-7717AFB7-0F03-43C7-B336-CF9DCB2B6011Q33878023-9BE2C4D3-5517-48DB-9790-1D6FA1D2AEA4Q34016054-D2A05B56-C7F5-4794-8E42-614398882968Q34172400-83923D15-08AF-4C2C-A0D3-3FF22F22BD6BQ34637674-CE879194-F667-4166-8923-497B424573A8Q34699002-6BC4D76E-5C0E-4514-9AD8-04F8B324290EQ35087471-96540432-7434-4D4C-8246-4806A41408D6Q35179957-F7E1A40D-0B8D-4CBF-9CC1-C1A3257B4B3DQ35350503-A673C4EC-51A6-4EDE-B879-C74607117641Q35485760-B2D25F9B-9159-46D2-BA87-623853AC322FQ35574984-795D566C-FCE3-4CA1-8E1B-C39A89EA31B0Q35584874-457FED12-63BA-46DC-9A77-C6C70E0369AFQ35944957-9087501B-CE15-4AE2-B467-2ED6B552D342Q36134847-492CA4B8-79D6-4A87-846B-CDF682A55D8CQ36319022-3D65E94A-B819-42D3-9568-5F943BF060D0Q36389712-F4FC9BE0-C44D-4F1D-9F3A-9FDE34770150Q37337552-0E4543CE-5C75-4880-9734-843A27CC901FQ37351838-3AA9EE09-B9AE-401A-B080-674D3C0F3B5EQ37375113-06840D9A-DD09-482F-ABEA-2338E455C645Q38210942-9F8A8E37-3E24-4167-9FF8-919434284CB1Q40798113-76622E8C-ACFE-41FD-BB50-11BF1A1FCCF1Q41240732-8D06B2C1-AB9E-4C0D-AF78-6D89E06658BAQ41952967-F31DD1B4-2034-48DB-A802-86094E912E59Q42111358-967FD98D-A0CF-46B8-9705-A34E34A562C4Q42113698-1D0DB069-C7FD-4C93-8F4A-2E51350A9537Q42750577-EF16F392-F6DC-4C22-BB44-924FC6476683Q43278321-CFF1DEA6-4721-4A2B-9E0B-7F1483A0BC59Q46478541-B8892B7C-DABE-4F0F-BAC1-28686082096EQ48051219-1392A767-0A59-4D37-ACD9-57B390B6B8C0Q48402332-2A8C039D-B1CD-419C-B9DC-FA4DE2E70398Q50103355-0CE4E7D4-BEA2-44AE-828D-35194C34978B
P2860
The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The Rochester Diabetic Neuropa ...... diagnosis and staged severity.
@en
type
label
The Rochester Diabetic Neuropa ...... diagnosis and staged severity.
@en
prefLabel
The Rochester Diabetic Neuropa ...... diagnosis and staged severity.
@en
P2093
P356
P1433
P1476
The Rochester Diabetic Neuropa ...... diagnosis and staged severity.
@en
P2093
P304
P356
10.1212/WNL.42.6.1164
P407
P577
1992-06-01T00:00:00Z